BRUKINSO Trademark

Trademark Overview

On Thursday, May 13, 2021, a trademark application was filed for BRUKINSO with the United States Patent and Trademark Office. The USPTO has given the BRUKINSO trademark a serial number of 90708204. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 17, 2023. This trademark is owned by BeiGene, Ltd.. The BRUKINSO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
brukinso

General Information

Serial Number90708204
Word MarkBRUKINSO
Filing DateThursday, May 13, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements

Goods and Servicespharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBeiGene, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSan Mateo, CA 94404
Party NameBeiGene, Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGrand Cayman KY1-1108
KY

Trademark Events

Event DateEvent Description
Monday, July 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 24, 2022SOU EXTENSION 2 GRANTED
Monday, October 24, 2022SOU EXTENSION 2 FILED
Monday, October 24, 2022TEAS EXTENSION RECEIVED
Tuesday, March 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 25, 2022SOU EXTENSION 1 GRANTED
Friday, March 25, 2022SOU EXTENSION 1 FILED
Friday, March 25, 2022TEAS EXTENSION RECEIVED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 14, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 8, 2021ASSIGNED TO EXAMINER
Thursday, August 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 17, 2021NEW APPLICATION ENTERED

Related Keywords

brukinso diseases infectious inflammatory autoimmune treatment cancer pharmaceuticals